Evidence map›Paper›PMID 42706041›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2026

[Exploration of antiviral regimens for patients with chronic hepatitis B virus infection in the indeterminate phase].

J Zheng, X W Li, L Long, X Liu, S Yuan, S P Wang, L C Cheng, X Wang, G Y Long

Abstract read
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

J ZhengDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.
X W LiDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.
L LongDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.
X LiuDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.
S YuanDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.
S P WangDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.
L C ChengDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.
X WangDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.
G Y LongDepartment of Health and Epidemic Prevention, Armed Police Force Hospital of Sichuan, Leshan 614000, China.

Funding

Leshan Science and Technology Project 2023-23ZDYJ0141
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antiviral AgentsHepatitis B, ChronicInterferon-alphaPolyethylene GlycolsAdultAlanine TransaminaseDNA, ViralDrug Therapy, CombinationFemaleHepatitis B e AntigensHepatitis B Surface AntigensHepatitis B virusHumansInterferon alpha-2MaleMiddle AgedAlanine TransaminaseAntiviral AgentsDNA, ViralHepatitis B e AntigensHepatitis B Surface AntigensInterferon-alphaInterferon alpha-2peginterferon alfa-2bPolyethylene GlycolsRecombinant Proteins

Identifiers

PMID42706041
PMCPMC13529421

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.